Health and Healthcare

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Lee Jackson | Mar 16, 2018 at 10:50 AM EDT

JPMorgan Has 3 Top Biotechnology Picks With Huge Upside Potential

These three top companies have solid catalyst potential and already have shown good clinical results on their leading assets.

Chris Lange | Mar 15, 2018 at 12:25 PM EDT

Alexion Wins Big in Late-Stage Trial

Alexion Pharmaceuticals watched its shares make a solid gain on Thursday after the firm announced positive results from its late-stage…

Chris Lange | Mar 13, 2018 at 4:08 PM EDT

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a down day for the broad U.S. markets. At first all three major indices started out positive, but…

Chris Lange | Mar 12, 2018 at 9:45 AM EDT

Major Biotechs: Tough Call for Short Sellers

The February 28 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Mar 8, 2018 at 11:50 AM EST

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in…

Chris Lange | Feb 28, 2018 at 9:15 AM EST

Major Biotechs Continue to See a Rising Tide of Short Interest

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech…

Chris Lange | Feb 12, 2018 at 9:15 AM EST

Major Biotechs See Rising Tide of Short Interest

The January 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 25, 2018 at 10:05 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The January 12 short interest data have been compared with the previous report, and short interest moves in the selected…

Jon C. Ogg | Jan 18, 2018 at 11:40 AM EST

Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018

Credit Suisse sees tax reform sparking a wave of mergers in the emerging pharmaceuticals space, which could produce sector outperformance.…

Chris Lange | Jan 11, 2018 at 9:50 AM EST

Short Sellers Grow More Selective on Major Biotechs

The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Jon C. Ogg | Jan 4, 2018 at 9:20 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap…

Chris Lange | Dec 30, 2017 at 8:55 AM EST

30 Big Biotech Events Coming in 2018

Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock…

Chris Lange | Dec 28, 2017 at 9:05 AM EST

Major Biotechs See Surge in Short Interest

The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech…

Lee Jackson | Dec 21, 2017 at 8:25 AM EST

RBC Out With Top Pick Biotech Stocks to Buy for 2018

A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for…

Jon C. Ogg | Dec 19, 2017 at 9:20 AM EST

Top Analyst Upgrades and Downgrades: Altria, Apple, GM, Procter & Gamble, Walmart and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Altria, Apple, General Motors, Procter & Gamble and Walmart.

1 … 6 7 8 9 10 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

JPMorgan Has 3 Top Biotechnology Picks With Huge Upside Potential

Alexion Wins Big in Late-Stage Trial

Tuesday’s Biggest Winners and Losers in the S&P 500

Major Biotechs: Tough Call for Short Sellers

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Major Biotechs Continue to See a Rising Tide of Short Interest

Major Biotechs See Rising Tide of Short Interest

Short Sellers Raise the Stakes in Major Biotechs

Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018

Short Sellers Grow More Selective on Major Biotechs

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

30 Big Biotech Events Coming in 2018

Major Biotechs See Surge in Short Interest

RBC Out With Top Pick Biotech Stocks to Buy for 2018

Top Analyst Upgrades and Downgrades: Altria, Apple, GM, Procter & Gamble, Walmart and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

JPMorgan Has 3 Top Biotechnology Picks With Huge Upside Potential

Alexion Wins Big in Late-Stage Trial

Tuesday’s Biggest Winners and Losers in the S&P 500

Major Biotechs: Tough Call for Short Sellers

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Major Biotechs Continue to See a Rising Tide of Short Interest

Major Biotechs See Rising Tide of Short Interest

Short Sellers Raise the Stakes in Major Biotechs

Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018

Short Sellers Grow More Selective on Major Biotechs

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

30 Big Biotech Events Coming in 2018

Major Biotechs See Surge in Short Interest

RBC Out With Top Pick Biotech Stocks to Buy for 2018

Top Analyst Upgrades and Downgrades: Altria, Apple, GM, Procter & Gamble, Walmart and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do